The third edition of the J-DAC conference has been announced, continuing its focus on a One Health approach to atopic dermatitis, which examines the condition across both human and animal medicine.
This year's program will center on Janus kinase inhibitors, known as JAKi, described as one of the most significant recent therapeutic advancements in the field. The event aims to bridge human and veterinary medicine by contrasting more than 13 years of veterinary clinical experience with the latest developments in human dermatology.
Speakers confirmed for the event include ISAD President Prof. Alain TAIEB, along with Prof. Sebastien BARBAROT, Prof. Daniel COMBARROS, Dr. Severine BOULLIER, and Dr. Pascal PRELAUD.
The conference is described as a morning dedicated to critical discussion and cross-disciplinary exchange, offering insights into the future management of atopic dermatitis.
J-DAC 2026 will take place on September 12, 2026, at La Manufacture in Issy-les-Moulineaux, France. More information and registration details are available at www.j-dac.com.